Skip to content

Acadia Pharmaceuticals ACAD Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin91.5%-0.2pp91.7%-0.2pp91.9%-0.1pp92%-0.1pp92%+0.6pp
Operating margin7.4%-2.4pp9.8%-13.2pp23%
Net margin34.3%-2.2pp36.5%+11.5pp24.9%+3.1pp21.8%-1.2pp23%-0.7pp
Returns
Return on equity37.3%-2.6pp39.9%+4.9pp35%+1.8pp33.2%-4.1pp37.2%-1.7pp
Return on invested capital10%-3.4pp13.4%-25.4pp38.8%
Efficiency
Asset turnover0.8×0.0×0.8×-0.1×0.9×0.0×-0.1×0.0×
Liquidity
Current ratio3.6×-0.2×3.8×+0.8×+0.1×2.9×0.0×2.9×+0.5×
Leverage
Debt-to-equity0.0×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Net debt / EBITDA-2.5×-1.4×-1.1×-0.3×-0.8×
Per Share
Book value per share$7.230.0%$7.22+34.4%$5.38+10.3%$4.88+6.8%$4.56+3.6%
Valuation
Market capitalization$3.8B-16.0%$4.52B+25.5%$3.6B-4.0%$3.75B+35.4%$2.77B-9.3%
Price / earnings10.1×-1.5×11.6×-2.2×13.8×-3.1×16.9×+4.8×12.1×
Price / sales3.5×-0.8×4.2×+0.8×3.4×-0.2×3.7×+0.9×2.8×-0.4×
Price / book-0.6×3.7×-0.2×3.9×-0.6×4.6×+0.9×3.6×-0.5×
EV / EBITDA38.4×+0.8×37.7×+24.4×13.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Acadia Pharmaceuticals's profit margins?
Acadia Pharmaceuticals (ACAD) runs a 91.5% gross margin and a 7.4% operating margin, with a 34.3% net margin.
Where do Acadia Pharmaceuticals's ratios come from?
Every ratio is computed from Acadia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.